Concept: Treatment of Major Depression
Molecular imaging links late-life depression to neurotransmitter and Alzheimer’s changes
How molecular imaging reveals brain changes underlying depression in older adults
Zuranolone was approved for postpartum depression, not major depressive disorder
How expedited drug approval processes may compromise regulatory safety standards
Dysfunctional metacognitive beliefs may contribute to interpersonal distress
Metacognitive beliefs as a predictor of interpersonal distress over time
Reasoning-based LLMs may predict antidepressant response
AI predicts which depression patients will respond to antidepressants within 12 weeks
CBT outcomes linked more to sessions attended than session rate
More sessions help more than faster sessions in treating depression and anxiety
